BioValley-BiONwoven – Revolutionary Next-Generation Bio-textiles – A Circular Innovation combats SEPSIS
Drug-resistant hospital infections leading to SEPSIS are a global health challenge, with mortality rates reaching 30% shortly after infection and 20% within a year. The main (60%) sources of infection are contaminated textiles and the patient’s immediate surroundings. In response, we have developed a biocidal material that aligns with the principles of the circular economy: it is self-sterilizing, biodegradable, environmentally friendly, and cost-effective to produce.
The material has been tested in renowned laboratories (Lukasiewicz Research Network, Lodz University of Technology, Polish Academy of Sciences), confirming its antibacterial, antiviral, anti-fungal, and anti-mouldy effectiveness in accordance with EU standards. It is soft, requires no washing, and is compostable—making it safe to return to the biological cycle after use.
Its application in hospitals—as bedding, clothing, curtains, or dressings—reduces pathogen transmission, lowers the risk of SEPSIS, and cuts textile maintenance costs. After use, it can be transformed into biofertilizer, enriching soil without harming the environment. Our BIONWOVEN technology exemplifies a circular approach: from production, through use, to safe end-of-life reintegration. Following successful lab tests—where samples remained sterile for six months—we are ready for implementation in both hospital and agricultural settings, offering a solution that combines innovation with ecological responsibility.